Logo image of VISTN.OL

VISTIN PHARMA ASA (VISTN.OL) Stock Price, Forecast & Analysis

Europe - Euronext Oslo - OSL:VISTN - NO0010734122 - Common Stock

20.4 NOK
-0.1 (-0.49%)
Last: 12/10/2025, 7:00:00 PM

VISTN.OL Key Statistics, Chart & Performance

Key Statistics
Market Cap904.54M
Revenue(TTM)451.83M
Net Income(TTM)76.10M
Shares44.34M
Float18.21M
52 Week High27.3
52 Week Low19.4
Yearly Dividend0
Dividend Yield6.31%
EPS(TTM)1.72
PE11.86
Fwd PEN/A
Earnings (Next)02-16 2026-02-16
IPO2015-06-10
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


VISTN.OL short term performance overview.The bars show the price performance of VISTN.OL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

VISTN.OL long term performance overview.The bars show the price performance of VISTN.OL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 20

The current stock price of VISTN.OL is 20.4 NOK. In the past month the price decreased by -0.97%. In the past year, price decreased by -14.29%.

VISTIN PHARMA ASA / VISTN Daily stock chart

VISTN.OL Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
SAN.PA SANOFI 11.01 203.16B
SNW.DE SANOFI 10.85 200.34B
1SAN.MI SANOFI 10.85 200.32B
MRK.DE MERCK KGAA 13.96 51.78B
UNC.DE UCB SA 37.74 47.13B
UCB.BR UCB SA 37.49 46.82B
BAYN.DE BAYER AG-REG 6.8 35.69B
1BAYN.MI BAYER AG-REG 6.78 35.58B
IPN.PA IPSEN 11.83 10.18B
REC.MI RECORDATI INDUSTRIA CHIMICA 24.41 10.05B
TUB.BR FINANCIERE DE TUBIZE 103.85 9.61B
VIRP.PA VIRBAC SA 19.67 2.86B

About VISTN.OL

Company Profile

VISTN logo image Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.

Company Info

VISTIN PHARMA ASA

Ostensjoveien 27

Oslo OSLO NO

Employees: 73

VISTN Company Website

VISTN Investor Relations

Phone: 4748926506

VISTIN PHARMA ASA / VISTN.OL FAQ

What does VISTN do?

Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The firm is engaged in the pharmaceuticals industry. The firm is a producer and supplier of Active Pharmaceutical Ingredients (APIs), which are used in medications for diabetes. Vistin Pharma offering such products: Metformin HCl (API); Metformin DC (direct compressible granules); Customized Particle Distribution (PSD) and Premix (Metformin + MgSt, can be delivered on-request). The Company’s customers are pharmaceutical companies worldwide.


What is the stock price of VISTIN PHARMA ASA today?

The current stock price of VISTN.OL is 20.4 NOK. The price decreased by -0.49% in the last trading session.


What is the dividend status of VISTIN PHARMA ASA?

VISTIN PHARMA ASA (VISTN.OL) has a dividend yield of 6.31%. The yearly dividend amount is currently 0.


What is the ChartMill technical and fundamental rating of VISTN stock?

VISTN.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the number of employees for VISTIN PHARMA ASA?

VISTIN PHARMA ASA (VISTN.OL) currently has 73 employees.


Can you provide the ownership details for VISTN stock?

You can find the ownership structure of VISTIN PHARMA ASA (VISTN.OL) on the Ownership tab.


VISTN.OL Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

VISTN.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to VISTN.OL. VISTN.OL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VISTN.OL Financial Highlights

Over the last trailing twelve months VISTN.OL reported a non-GAAP Earnings per Share(EPS) of 1.72. The EPS increased by 11.41% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.84%
ROA 18.05%
ROE 25.86%
Debt/Equity 0.14
Chartmill High Growth Momentum
EPS Q2Q%-3.59%
Sales Q2Q%10.92%
EPS 1Y (TTM)11.41%
Revenue 1Y (TTM)3.23%

VISTN.OL Forecast & Estimates


Analysts
Analysts40
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

VISTN.OL Ownership

Ownership
Inst Owners14.3%
Ins Owners5.62%
Short Float %N/A
Short RatioN/A